Clinical Trials

See all trials

1 studies in Division of Pulmonary and Critical Care Medicine in Phoenix/Scottsdale, AZ.

  1. A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

    Rochester, Minn., Jacksonville, Fla., Phoenix/Scottsdale, Ariz. View Summary

    A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

    Location:

    Rochester, Minn., Jacksonville, Fla., Phoenix/Scottsdale, Ariz.

    Trial status:

    Open for Enrollment

    Why is this study being done?

    This study is to evaluate the efficacy and safety of simtuzumab (GS-6624) in adults with idiopathic pulmonary fibrosis.

    NCT ID:

    NCT01769196

    IRB Number:

    13-000529

    Who can I contact for additional information about this study?

    Rochester: Suson Walsh 507-293-0637
                        
    Scottsdale: Michaele Menghini 480-301-6651
                        
    Jacksonville: Pamela Long 904-953-7719